{"title": "The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target", "author": "Arlene Weintraub", "url": "https://www.fiercebiotech.com/research/link-between-covid-19-rattlesnake-venom-and-a-killer-enzyme-inspires-treatment-target", "hostname": "fiercebiotech.com", "description": "University of Arizona Professor Floyd (Ski) Chilton, Ph.D., has been studying an enzyme related to rattlesnake venom for 30-plus years. | University of Arizona researchers led a study that found that levels of the inflammatory enzyme sPLA2-IIA could predict severe COVID-19. With further research, the enzyme, which is similar to a paralyzing enzyme in rattlesnake venom, could be a viable therapeutic target, they suggested.", "sitename": "FierceBiotech", "date": "2021-08-24", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}